News Articles Tagged: EGFR TKI

Osimertinib (AZD-9291): A Key Player in Modern NSCLC Treatment Strategies

Explore the role of Osimertinib (AZD-9291) in treating EGFR T790M NSCLC and NINGBO INNO PHARMCHEM CO.,LTD.'s commitment to pharmaceutical ingredient quality.

The Role of AZD3759 in Advancing Brain Metastasis Treatment for NSCLC

Explore AZD3759's role in treating NSCLC brain metastases, highlighting its superior CNS penetration and efficacy as a potent EGFR TKI.

Focus on AZD3759: Advancing Treatment for Lung Cancer with CNS Involvement

Learn about AZD3759, a potent EGFR TKI with superior CNS penetration, offering new hope for EGFR-mutant NSCLC patients with brain metastases.

The Science Behind AZD3759: A New Era for Lung Cancer Brain Metastasis Treatment

Delve into the scientific advancements of AZD3759, a CNS-penetrant EGFR TKI revolutionizing lung cancer care, particularly for EGFR-mutant NSCLC with brain metastases.